���Quotane���[Glaxo-SmithKline]

Keyword(s):  
Author(s):  
A. Ganesan ◽  
D. Antoine ◽  
A. Palanisammi ◽  
R. Ramprabu

Background: Canine pyometra is a common reproductive disorder of sexually intact bitches characterized by accumulation of pus in the uterine lumen and it is always associated with vagaries of clinical and pathological manifestations of multisystemic origin. Methods: The present study involved twenty three bitches of 8- 13 years of age with pyometra. Diagnosis of pyometra was performed based on the anamnesis, ultrasound examination, hematoglocial and biochemical changes. As an alternate to conventional prostaglandin protocol, Tab. Methylergometrine 0.125 mg/dog (Methergine, Novartis) BID and Tab. Cabergoline @ 10 µg/kg body weight (Cabgolin, Sun Pharma) SID and Tab. Amoxicillin- Clavulinic acid @ 10 mg/kg body weight (Augmentin, Glaxo Smithkline) BID was advised for two weeks. In addition to that supportive fluid therapy and Inj. Pantoprazole @ 1 mg/kg body weight was also administered prior to initiation of treatment protocol. There was a significant clinical recovery in terms of physiological, hematological and biochemical parameters. Ultrasound examination on Day 0, 7, 9 and Day 14 of treatment revealed reduction in the diameter of uterine sacculations. All the bitches recovered after 10 to 15 days with complete evacuation of pus, with no recurrence. Result: Our investigation revealed that this alternative protocol along with antibiotics and supportive fluid therapy can be a better alternative to young dogs to preserve the reproductive capability and also in geriatric dogs which are unfit for traditional ovariohysterectomy.


2000 ◽  
Vol 118 (3) ◽  
pp. 460
Author(s):  
Dan Gordon
Keyword(s):  

2001 ◽  
Vol 79 (32) ◽  
pp. 8
Author(s):  
ANN THAYER
Keyword(s):  

2006 ◽  
Vol 10 (02) ◽  
pp. 249-259
Author(s):  
Nitin Pangarkar ◽  
Yuen Kay Chung

The economic ups and downs since the eruption of the Asian crisis in 1997 had prompted a wave of restructurings and job losses in Singapore and several other Asian countries. As a response, policy-makers in the Singapore government had urged companies to undertake wage reforms and to adopt more flexible wages. The wage restructuring exercise undertaken by the Singapore office of Glaxo Smithkline, one of the largest pharmaceutical companies in the world, in 2002 is studied in this case. Since the merger of Glaxo Welcome and SmithKline Beecham two years earlier, there had been consolidation with the less efficient plants in the system closing down. Although the Singapore plants were performing well, the impetus to restructure wages came primarily from a more competitive internal and external environment. Management believed that the introduction of Performance Bonus (PB) would lead to improved metrics and was essential for the company to compete in the changed environment. While the Union leadership was in broad agreement that the plant needed to remain competitive, it had some initial misgivings about the proposals put forth by management. This case charts the process of the wage restructuring exercise, illustrating some of the challenges that companies may face in implementing wage restructuring initiatives. We also examine the impact of different factors, as well as the process of implementation, on the success of such initiatives.


Sign in / Sign up

Export Citation Format

Share Document